The Nitric Oxide Donors, SNAP and DEA/NO, Exert a Negative Inotropic Effect in Rat Cardiomyocytes which is Independent of Cyclic GMP Elevation

1999 ◽  
Vol 31 (4) ◽  
pp. 799-808 ◽  
Author(s):  
Lakshman Sandirasegarane ◽  
Jack Diamond
2000 ◽  
Vol 522 (2) ◽  
pp. 311-320 ◽  
Author(s):  
Gerhard Müller‐Strahl ◽  
Karin Kottenberg ◽  
Heinz‐Gerd Zimmer ◽  
Eike Noack ◽  
Georg Kojda

2017 ◽  
Vol 7 (3) ◽  
pp. 267-271 ◽  
Author(s):  
Bingyan Guo ◽  
Yongjun Li ◽  
Xin Jin ◽  
Suyun Liu ◽  
Chenglong Miao

2004 ◽  
Vol 141 (4) ◽  
pp. 653-660 ◽  
Author(s):  
Sara M Thomazzi ◽  
Juliana Moreira ◽  
Sisi Marcondes ◽  
Gilberto De Nucci ◽  
Edson Antunes

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Christiane Trimpert ◽  
Stephan B Felix ◽  
Andreas Greinacher ◽  
Katrin Birkenmeier ◽  
Alexander Staudt

Introduction : Recently we detected the FcγII receptor on rat and human cardiomyocytes. Binding of cardiac antibodies obtained from DCM-patients to this receptor induced negative inotropic effects. The mechanism of these effects remains to be elucidated. Methods: Isolated adult rat cardiomyocytes stained with Fura-2-AM were field-stimulated (1 Hz, 12 V). The relative change of the calcium transients and systolic cell shortening due to superfusion with a polyclonal goat-antibody against the FcγII receptor (10 μg/ml) were recorded with a dual-excitation fluorescence microscope. For inhibition of possible involved tyrosine kinases we used PP2 (1μM) and specific syk-Kinase inhibitors. Results: Superfusion of rat cardiomyocytes with anti-FcγII-receptor antibody induces a negative inotropic effect. The tested concentrations (6 μg/ml, 8 μg/ml, 10 μg/ml and 16 μg/ml) show a clear dose-response-relationship. The contractility of the cells decreases after 2 min by −5,3%, −11,5%, −14,2% and −18,3% from baseline as well as the Ca 2+ -Ratio (−9,5%, −11,2%, −12,2%, −15,6%). The negative inotropic reaction could be blocked by preincubation of the cells with the tyrosine kinase inhibitor PP2 (change of contractility/Ca2+-Ratio from baseline: −1, 3%/−2,4%, p<0,001). Cells preincu-bated with specific inhibitors for syk-Kinases did not show a negative inotropic reaction after superfusion with the antibody (change of contractility/Ca 2+ -ratio from baseline +0,7%/−5,5%, p<0,05). A polyclonal goat control antibody (anti-CD45, c = 10 μg/ml)) did not trigger a reaction (change from baseline for contractility/Ca2+-Ratio: −3%/−2,4%, p<0,001). Conclusion: The inhibition of the negative inotropic effect of antibodies against FcγII receptor shows an involvement of Kinases in the signalling pathway like described for other cell types.


2001 ◽  
Vol 19 (7) ◽  
pp. 1289-1293 ◽  
Author(s):  
Beril Tom ◽  
René de Vries ◽  
Pramod R. Saxena ◽  
A. H. Jan Danser

2012 ◽  
Vol 302 (5) ◽  
pp. H1131-H1137 ◽  
Author(s):  
Ana Luísa Pires ◽  
Marta Pinho ◽  
Cristina Maria Sena ◽  
Raquel Seica ◽  
Adelino F. Leite-Moreira

Intermedin (IMD) is a novel vasoactive peptide from the calcitonin gene-related peptide (CGRP) implicated in cardiac regulation, yet the contractile effects of IMD remain controversial, since previous studies in vivo and isolated cardiomyocytes documented contradictory results. We hypothesized cardiac endothelial cells involvement in IMD modulation of cardiac function as an explanation for these opposing observations. With this in mind, we investigated the direct action of increasing concentrations of IMD (10−8 to 10−6M) on myocardial performance parameters in rat left ventricular (LV) papillary muscles with and without endocardial endothelium (EE) and in presence of receptor antagonists and intracellular pathways inhibitors. In LV papillary muscles with intact EE, IMD induced a concentration-dependent negative inotropic action (%decrease relative to baseline, at IMD concentration of 10−6M, active tension of 14 ± 4%, and maximum velocity of tension rise of 10 ± 4%). These effects were blunted by EE removal, AM receptor antagonist (AM22–52), and CGRP receptor antagonist (CGRP8–37). Additionally, nitric oxide (NO) synthase inhibition with NG-nitro-l-arginine (l-NAME) in muscles with and without EE and guanylyl cyclase inhibition with {1 H-[1,2,4]oxadiazole-[4,4-a]-quinoxalin-1-one} not only blunted the negative inotropic action of IMD but also unmasked IMD-positive inotropic effect dependent on CGRP receptor PKA activation. Western blot quantification of phosphorylated cardiac troponin I (P-cTnI) in IMD-treated papillary muscles revealed a significant increase in P-cTnI when compared with untreated muscles, while in l-NAME-pretreated papillary muscles IMD failed to increase P-cTnI. Finally, we found that stimulation of both EE and microvascular endothelial cells with IMD significantly increased NO production by 40 ± 3 and 38 ± 3%, respectively, suggesting the role of cardiac endothelial cells in NO production upon IMD stimulation. Our findings establish IMD negative inotropic effect in isolated myocardium due to NO/cGMP pathway activation with concomitant thin myofilament desensitization by increase in cTnI phosphorylation and provide a coherent explanation for the previously reported contradictory results.


Sign in / Sign up

Export Citation Format

Share Document